Search

Your search keyword '"Nakagawara, Kensuke"' showing total 163 results

Search Constraints

Start Over You searched for: Author "Nakagawara, Kensuke" Remove constraint Author: "Nakagawara, Kensuke" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
163 results on '"Nakagawara, Kensuke"'

Search Results

1. Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force

2. Association between ABO blood group/genotype and COVID-19 in a Japanese population

3. CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome

4. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020–2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society

6. Integrated assessment of computed tomography density in pectoralis and erector spinae muscles as a prognostic biomarker for coronavirus disease 2019

7. Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 h: a retrospective cohort study

8. Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography – a multicenter retrospective cohort study in Japan

9. Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study

10. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

11. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity

12. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

13. Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force

14. U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force

15. Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

16. Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

17. Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics

18. Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

19. Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19

20. Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity

22. Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations

23. Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells

24. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences

27. Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force

28. Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

29. Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-19

30. Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

31. Characteristics and Clinical Effectiveness of COVID-19 Vaccination in Hospitalized Patients in Omicron-dominated Epidemic Wave – A Nationwide Study in Japan

32. Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

33. Additional file 8 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

34. Additional file 6 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

35. Additional file 4 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

36. Additional file 5 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

37. Additional file 2 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

38. Additional file 1 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

39. Additional file 7 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

40. Additional file 3 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

41. Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 hours: a retrospective cohort study

42. Diagnostic significance of secondary bacteremia in patients with COVID-19

43. Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant

44. Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant

45. Association between ABO blood group/genotype and COVID-19 in a Japanese population

46. Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

47. Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

48. Early-phase efficacy and adverse effects of liposomal amikacin inhalation for refractory Mycobacterium avium complex lung disease: A case series

49. Additional file 1 of Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

50. Comprehensive Analysis of Long COVID in a Japanese Nationwide Prospective Cohort Study

Catalog

Books, media, physical & digital resources